Valneva SE | Mutual Funds
Mutual Funds that own Valneva SE
Apus Capital Revalue Fonds
740,000
0.95%
80,000
1.88%
09/30/2017
Lupus alpha Fonds - All Opportunities Fund
500,000
0.64%
50,000
1.84%
12/31/2017
SK Invest - Flexibel
400,000
0.52%
100,000
0.7%
03/31/2018
DFA Continental Small Company Series
322,635
0.42%
9,208
0.02%
01/31/2018
MOZART One
309,008
0.4%
60,000
1.61%
12/31/2017
FCP OP Medical BioHe@lth-Trends
301,057
0.39%
0
0.8%
11/30/2017
WSS - Europa
300,000
0.39%
300,000
4.59%
02/28/2018
SK Invest - Dynamisch
250,000
0.32%
250,000
1.04%
03/31/2018
232,000
0.3%
0
1.37%
07/31/2018
GEFIP Euroland
231,084
0.3%
0
2.31%
06/30/2017
| Address |
Campus Bio-Ouest 6
Saint-Herblain Lorraine 44800
France
|
|
Employees
|
- |
| Website |
http://www.valneva.com |
| Updated |
07/08/2019 |
| Valneva SE is a biotech company which engages in the development, production, and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services, and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. |
